Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

Samjin Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Jul 31, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Market Capitalization	216,350	344,067	327,511	140,529	104,902	150,669
Market Cap Growth	-12.62%	5.05%	133.05%	33.96%	-30.38%	-5.60%
Enterprise Value	-	389,035	372,478	160,616	157,311	189,264
Last Close Price	17650.00	22749.65	22613.91	7248.64	5257.09	7333.72

Price Ratios

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Jul 31, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
PE Ratio	10.22	15.72	11.53	13.21	14.85	14.38
PS Ratio	0.79	1.26	1.31	0.76	0.52	0.75
PB Ratio	0.78	1.25	1.40	1.25	0.88	1.26
P/TBV Ratio	0.82	1.30	1.46	1.27	0.89	1.28
P/FCF Ratio	-	-	-	6.60	79.58	11.66
P/OCF Ratio	12.51	19.90	13.67	4.14	8.28	8.95

EV Ratios

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Jul 31, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
EV/Sales Ratio	-	1.42	1.49	0.87	0.78	0.94
EV/EBITDA Ratio	-	11.79	9.03	7.51	5.79	7.58
EV/EBIT Ratio	-	16.78	10.98	9.28	6.58	8.57
EV/FCF Ratio	-	-	-	7.55	119.33	14.65

Financial Efficiency

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Jul 31, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Debt / Equity Ratio	0.32	0.32	0.23	0.38	0.35	0.34
Debt / EBITDA Ratio	2.65	2.65	1.32	2.01	1.53	1.64
Debt / FCF Ratio	-	-	-	2.02	31.44	3.17
Net Debt / Equity Ratio	0.30	0.30	0.18	0.29	0.30	0.28
Net Debt / EBITDA Ratio	2.51	2.51	1.04	1.55	1.34	1.36
Net Debt / FCF Ratio	-4.59	-4.59	-0.88	1.56	27.55	2.63
Asset Turnover	0.74	0.74	-	0.90	1.01	1.06
Inventory Turnover	2.26	2.26	-	3.09	3.26	3.32
Quick Ratio	0.79	0.79	1.40	1.51	1.74	2.12
Current Ratio	1.64	1.64	2.83	1.89	2.09	2.60
Return on Equity (ROE)	8.59%	8.59%	-	9.15%	5.90%	9.14%
Return on Assets (ROA)	3.92%	3.92%	-	5.25%	7.48%	7.29%
Return on Invested Capital (ROIC)	6.33%	6.33%	13.05%	8.10%	4.99%	9.50%
Return on Capital Employed (ROCE)	7.10%	7.10%	12.00%	13.00%	17.30%	16.10%

Yields

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Jul 31, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Earnings Yield	10.12%	6.36%	8.67%	7.57%	6.73%	6.95%
FCF Yield	-8.35%	-5.25%	-14.83%	15.14%	1.26%	8.58%
Dividend Yield	4.51%	3.52%	3.54%	-	-	0.68%
Payout Ratio	44.95%	44.95%	34.65%	26.91%	9.07%	3.56%
Buyback Yield / Dilution	2.00%	-3.00%	5.52%	0.07%	1.42%	0.02%
Total Shareholder Return	6.51%	0.52%	9.06%	0.07%	1.42%	0.70%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2013

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error